Sheel Biotech
SHEEL NSE
Sheel Biotech
ServicesNSE: SHEEL Commercial Services & Supplies
Key Fundamentals
SMEDiversified ServicesCommercial ServicesMarket Cap
₹120 Cr
Volatility
Moderate
P/E Ratio
10.7
EBITDA
₹16.28 Cr
Return on Equity
12.68%
Debt to Equity
0.2
Book Value
₹62.4
52W High
₹95.55
52W Low
₹37.8
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has delivered good profit growth of 20.1% CAGR over last 5 years
Weaknesses
2- The company has delivered a poor sales growth of 11.8% over past five years.
- Company has high debtors of 183 days.
Growth Rate
Revenue Growth
7.55% higher than
3Y
Net Income Growth
9.34% lower than
3Y
Cash Flow Change
—
ROE
-12.01% lower than
3Y
ROCE
-0.85% lower than
3Y
EBITDA Margin (Avg.)
-2.97% higher than
3Y
Quarterly Results
| Particulars | Sep 2024 | Sep 2025 |
|---|---|---|
| Sales | 11 | 22 |
| Expenses | 14 | 20 |
| Operating Profit | -2 | 2 |
| OPM % | -22% | 8% |
| Other Income | 0 | 0 |
| Interest | 1 | 1 |
| Depreciation | 0 | 1 |
| PBT | -4 | 0 |
| Tax % | 3% | 24% |
| Net Profit | -4 | 0 |
| EPS in Rs | -2.53 | 0.13 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 63 | 84 | 89 | 103 | 110 | 110 |
| Expenses | 56 | 78 | 80 | 89 | 95 | 94 |
| Operating Profit | 7 | 6 | 9 | 14 | 15 | 16 |
| OPM % | 10% | 8% | 10% | 14% | 14% | 15% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| PBT | 5 | 5 | 6 | 12 | 13 | 14 |
| Tax % | 0% | 2% | 20% | 15% | 17% | 16% |
| Net Profit | 5 | 5 | 5 | 10 | 11 | 12 |
| EPS in Rs | 11.58 | 10.88 | 12.26 | 25.27 | 7.12 | 5.78 |
| Div. Payout % | 0% | 28% | 25% | 12% | 14% | 0% |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 15 | 15 |
| Reserves | 53 | 56 | 59 | 69 | 69 | 69 |
| Borrowings | 21 | 24 | 19 | 24 | 17 | 27 |
| Other Liabilities | 4 | 10 | 11 | 10 | 12 | 13 |
| Total Liabilities | 82 | 93 | 94 | 106 | 113 | 124 |
| Fixed Assets | 8 | 8 | 8 | 7 | 7 | 7 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 75 | 84 | 85 | 98 | 105 | 116 |
| Total Assets | 82 | 93 | 94 | 106 | 113 | 124 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | — | 2 | 9 | -1 | 9 | -18 |
| Investing | — | -2 | -2 | 0 | -2 | -7 |
| Financing | — | 0 | -7 | 2 | -7 | 26 |
| Net Cash Flow | — | 0 | 0 | 0 | 0 | 2 |
| Free Cash Flow | — | 1 | 8 | -1 | 8 | -24 |
| CFO/OP | — | 37 | 105 | 3 | 75 | -94 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 352 | 280 | 230 | 204 | 182 | — |
| Inventory Days | 55 | 120 | 177 | 263 | 272 | — |
| Days Payable | 30 | 85 | 75 | 37 | 29 | — |
| Cash Conversion Cycle | 377 | 315 | 332 | 430 | 426 | — |
| Working Capital Days | 348 | 274 | 255 | 256 | 253 | — |
| ROCE % | — | 7% | 10% | 15% | 14% | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sheel Biotech insights
29 extracted metrics + investor summaries across FY21–FY26.
Documents
1
Updates
10 Sep - Sheel Biotech Limited has informed regarding the finalisation of Commercial Transactions for Blueberry Project amounting to INR 14.53 Crores. 10 Sep - Sheel Biotech Limited has informed regarding the finalisation of Commercial Transactions for Blueberry Project amounting to INR 14.53 Crores.
2
Updates
9 Sep - Sheel Biotech Limited has informed regarding regarding Record Date & Book Closure for the purpose of 35th Annual General Meeting 9 Sep - Sheel Biotech Limited has informed regarding regarding Record Date & Book Closure for the purpose of 35th Annual General Meeting
3
Updates
2 Sep - Sheel Biotech Limited has informed regarding ''. Clarification on the monitoring agency report 2 Sep - Sheel Biotech Limited has informed regarding ''. Clarification on the monitoring agency report
4
Copy of Newspaper Publication
1 Sep - Mixed newspaper articles; no clear Sheel Biotech announcement. 1 Sep - Mixed newspaper articles; no clear Sheel Biotech announcement.
5
Monitoring Agency Report
1 Sep - MAR as required by NSE for the Half FY March-26 1 Sep - MAR as required by NSE for the Half FY March-26
Frequently Asked Questions about Sheel Biotech
What does Sheel Biotech Ltd do?
Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]
Where is Sheel Biotech Ltd (SHEEL) listed?
Sheel Biotech Ltd trades as SHEEL on the NSE.
Which sector does Sheel Biotech Ltd belong to?
Sheel Biotech Ltd is classified under the Services sector, in the Commercial Services & Supplies industry.
What is the market capitalisation of Sheel Biotech Ltd?
Sheel Biotech Ltd has a market capitalisation of ₹119.88 Cr, which places it in the Small Cap band.
What is the PE ratio of Sheel Biotech Ltd?
Sheel Biotech Ltd trades at a PE ratio of 10.70, against a book value of ₹62.4 per share.
What is the 52-week high and low of Sheel Biotech Ltd?
Over the last 52 weeks Sheel Biotech Ltd has traded between ₹37.8 and ₹95.55.
What is the Return on Equity (ROE) of Sheel Biotech Ltd?
Sheel Biotech Ltd reported a return on equity of 12.68%. Its debt-to-equity ratio is 0.20.
Company Information
Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHEEL.md for Sheel Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.